Bybee Clinton
- SEC CIK
- 0001219043
In the past year, 1 open-market purchase filing worth $12.5M and no sales.
Current role at each company
- BOLD Boundless Bio, Inc.10% Owneras of Jul 6, 2026
- LYEL Lyell Immunopharma, Inc.10% Owneras of Mar 9, 2026
- NMRA Neumora Therapeutics, Inc.10% Owneras of Oct 29, 2025
- SANA Sana Biotechnology, Inc.10% Owneras of Feb 12, 2024
- CDAK Codiak BioSciences, Inc.10% Owneras of Sep 15, 2022
Show 2 more companies
- VIR Vir Biotechnology, Inc.10% Owneras of Sep 7, 2022
- BEAM Beam Therapeutics Inc.10% Owneras of Jul 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $12.5M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$12.5M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bybee Clinton as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BOLD Boundless Bio, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 (view filing)4:30 PM ET | Apr 2 | 2 days | Crandell Keith and 3 others10% Owner | PPurchase | +200.0K | $16.00 | +$3.20M | +20.4%1.18M after | 2 lotsDuplicate filing |
| Jul 6, 2026 (view filing)5:44 PM ET | Jul 1 | 5 days | Crandell Keith and 4 others10% Owner | SSale | −16.0K | $2.49 | −$39.8K | −100.0%0 after | Duplicate filing |
LYEL Lyell Immunopharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 (view filing)4:34 PM ET | Mar 6 | 3 days | Berns Paul L and 8 others10% Owner | PPurchase | +488.1K | $25.61 | +$12.5M | +52.0%1.43M after |
NMRA Neumora Therapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 (view filing)6:16 AM ET | Sep 19 | 1 day | Crandell Keith and 7 others10% Owner | PPurchase | +1.50M | $17.00 | +$25.5M | +70.6%3.62M after | Duplicate filing |
| Oct 29, 2025 (view filing)7:21 PM ET | Oct 27 | 2 days | Crandell Keith and 6 others10% Owner | PPurchase | +1.92M | $2.61 | +$5.00M | +46.4%6.05M after | Duplicate filing |
SANA Sana Biotechnology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 (view filing)5:43 PM ET | Feb 8 | 4 days | Crandell Keith and 3 others10% Owner | PPurchase | +1.82M | $5.50 | +$10.0M | +17.1%12.4M after | 3 lotsDuplicate filing |
CDAK Codiak BioSciences, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 (view filing)6:53 PM ET | Sep 13 | 2 days | Crandell Keith and 6 others10% Owner | PPurchaseCommon Sotck | +5.00M | $1.50 | +$7.50M | +129.7%8.85M after | |
| Sep 15, 2022 (view filing)6:53 PM ET | Sep 13 | 2 days | Crandell Keith and 6 others10% Owner | PPurchase | +5.00M | – | – | –5.00M after | DerivativeDuplicate filing |